226 related articles for article (PubMed ID: 33052495)
1. Tubulin carboxypeptidase activity of vasohibin-1 inhibits angiogenesis by interfering with endocytosis and trafficking of pro-angiogenic factor receptors.
Kobayashi M; Wakabayashi I; Suzuki Y; Fujiwara K; Nakayama M; Watabe T; Sato Y
Angiogenesis; 2021 Feb; 24(1):159-176. PubMed ID: 33052495
[TBL] [Abstract][Full Text] [Related]
2. Vasohibin-1 has α-tubulin detyrosinating activity in glomerular podocytes.
Mifune T; Tanabe K; Nakashima Y; Tanimura S; Sugiyama H; Sato Y; Wada J
Biochem Biophys Res Commun; 2022 Apr; 599():93-99. PubMed ID: 35180473
[TBL] [Abstract][Full Text] [Related]
3. Vasohibins/SVBP are tubulin carboxypeptidases (TCPs) that regulate neuron differentiation.
Aillaud C; Bosc C; Peris L; Bosson A; Heemeryck P; Van Dijk J; Le Friec J; Boulan B; Vossier F; Sanman LE; Syed S; Amara N; Couté Y; Lafanechère L; Denarier E; Delphin C; Pelletier L; Humbert S; Bogyo M; Andrieux A; Rogowski K; Moutin MJ
Science; 2017 Dec; 358(6369):1448-1453. PubMed ID: 29146868
[TBL] [Abstract][Full Text] [Related]
4. Vasohibin-1 expression inhibits advancement of ovarian cancer producing various angiogenic factors.
Takahashi Y; Saga Y; Koyanagi T; Takei Y; Machida S; Taneichi A; Mizukami H; Sato Y; Matsubara S; Fujiwara H
Cancer Sci; 2016 May; 107(5):629-37. PubMed ID: 26893100
[TBL] [Abstract][Full Text] [Related]
5. Regulation of microtubule detyrosination by Ca2+ and conventional calpains.
Bär J; Popp Y; Koudelka T; Tholey A; Mikhaylova M
J Cell Sci; 2022 May; 135(9):. PubMed ID: 35373296
[TBL] [Abstract][Full Text] [Related]
6. Microtubule detyrosination by VASH1/SVBP is regulated by the conformational state of tubulin in the lattice.
Yue Y; Hotta T; Higaki T; Verhey KJ; Ohi R
Curr Biol; 2023 Oct; 33(19):4111-4123.e7. PubMed ID: 37716348
[TBL] [Abstract][Full Text] [Related]
7. Depletion of Vasohibin 1 Speeds Contraction and Relaxation in Failing Human Cardiomyocytes.
Chen CY; Salomon AK; Caporizzo MA; Curry S; Kelly NA; Bedi K; Bogush AI; Krämer E; Schlossarek S; Janiak P; Moutin MJ; Carrier L; Margulies KB; Prosser BL
Circ Res; 2020 Jul; 127(2):e14-e27. PubMed ID: 32272864
[TBL] [Abstract][Full Text] [Related]
8. Vasohibin-1 inhibits angiogenesis and suppresses tumor growth in renal cell carcinoma.
Zhao G; Na R; Li L; Xiao H; Ding N; Sun Y; Han R
Oncol Rep; 2017 Aug; 38(2):1021-1028. PubMed ID: 28656230
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of lysine acetyltransferases impairs tumor angiogenesis acting on both endothelial and tumor cells.
Di Martile M; Gabellini C; Desideri M; Matraxia M; Farini V; Valentini E; Carradori S; Ercolani C; Buglioni S; Secci D; Andreazzoli M; Del Bufalo D; Trisciuoglio D
J Exp Clin Cancer Res; 2020 Jun; 39(1):103. PubMed ID: 32498717
[TBL] [Abstract][Full Text] [Related]
10. Vasohibin 1 selectively regulates secondary sprouting and lymphangiogenesis in the zebrafish trunk.
de Oliveira MB; Meier K; Jung S; Bartels-Klein E; Coxam B; Geudens I; Szymborska A; Skoczylas R; Fechner I; Koltowska K; Gerhardt H
Development; 2021 Feb; 148(4):. PubMed ID: 33547133
[TBL] [Abstract][Full Text] [Related]
11. Knockout of vasohibin-2 reduces tubulin carboxypeptidase activity and increases paclitaxel sensitivity in ovarian cancer.
Koyanagi T; Saga Y; Takahashi Y; Tamura K; Yoshiba T; Takahashi S; Taneichi A; Takei Y; Urabe M; Mizukami H; Fujiwara H
Cancer Med; 2021 Apr; 10(8):2732-2739. PubMed ID: 33710778
[TBL] [Abstract][Full Text] [Related]
12. Parthenolide Destabilizes Microtubules by Covalently Modifying Tubulin.
Hotta T; Haynes SE; Blasius TL; Gebbie M; Eberhardt EL; Sept D; Cianfrocco M; Verhey KJ; Nesvizhskii AI; Ohi R
Curr Biol; 2021 Feb; 31(4):900-907.e6. PubMed ID: 33482110
[TBL] [Abstract][Full Text] [Related]
13. Cryptotanshinone inhibits VEGF-induced angiogenesis by targeting the VEGFR2 signaling pathway.
Xu X; Wu L; Zhou X; Zhou N; Zhuang Q; Yang J; Dai J; Wang H; Chen S; Mao W
Microvasc Res; 2017 May; 111():25-31. PubMed ID: 28040437
[TBL] [Abstract][Full Text] [Related]
14. Eriocalyxin B, a natural diterpenoid, inhibited VEGF-induced angiogenesis and diminished angiogenesis-dependent breast tumor growth by suppressing VEGFR-2 signaling.
Zhou X; Yue GG; Liu M; Zuo Z; Lee JK; Li M; Tsui SK; Fung KP; Sun H; Pu J; Lau CB
Oncotarget; 2016 Dec; 7(50):82820-82835. PubMed ID: 27756875
[TBL] [Abstract][Full Text] [Related]
15. Contribution of vascular endothelial growth factor receptor-2 sialylation to the process of angiogenesis.
Chiodelli P; Rezzola S; Urbinati C; Federici Signori F; Monti E; Ronca R; Presta M; Rusnati M
Oncogene; 2017 Nov; 36(47):6531-6541. PubMed ID: 28783175
[TBL] [Abstract][Full Text] [Related]
16. Cancer-Associated Fibroblasts Promote Angiogenesis of Hepatocellular Carcinoma by
Huang B; Huang M; Li Q
Technol Cancer Res Treat; 2019; 18():1533033819879905. PubMed ID: 31757187
[TBL] [Abstract][Full Text] [Related]
17. Vasohibins encode tubulin detyrosinating activity.
Nieuwenhuis J; Adamopoulos A; Bleijerveld OB; Mazouzi A; Stickel E; Celie P; Altelaar M; Knipscheer P; Perrakis A; Blomen VA; Brummelkamp TR
Science; 2017 Dec; 358(6369):1453-1456. PubMed ID: 29146869
[TBL] [Abstract][Full Text] [Related]
18. VASH1-SVBP and VASH2-SVBP generate different detyrosination profiles on microtubules.
Ramirez-Rios S; Choi SR; Sanyal C; Blum TB; Bosc C; Krichen F; Denarier E; Soleilhac JM; Blot B; Janke C; Stoppin-Mellet V; Magiera MM; Arnal I; Steinmetz MO; Moutin MJ
J Cell Biol; 2023 Feb; 222(2):. PubMed ID: 36512346
[TBL] [Abstract][Full Text] [Related]
19. Antiangiogenic mechanisms of PJ-8, a novel inhibitor of vascular endothelial growth factor receptor signaling.
Huang SW; Lien JC; Kuo SC; Huang TF
Carcinogenesis; 2012 May; 33(5):1022-30. PubMed ID: 22436611
[TBL] [Abstract][Full Text] [Related]
20. Essential role for endocytosis in the growth factor-stimulated activation of ERK1/2 in endothelial cells.
Gourlaouen M; Welti JC; Vasudev NS; Reynolds AR
J Biol Chem; 2013 Mar; 288(11):7467-7480. PubMed ID: 23341459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
